References - Therapeutic Strategies in Cancer Biology and Pathology - page 206

Denli, A.M., Tops, B.B., Plasterk, R.H., Ketting, R.F., Hannon, G.J., 2004. Processing of pri-
mary microRNAs by the microprocessor complex. Nature 432, 231-235.
Depeille, P., Young, J.J., Boguslawski, E.A., Berghuis, B.D., Kort, E.J., Resau, J.H., et al.,
2007. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor
release from endothelial cells expressing the human herpes virus 8 viral G protein-cou-
pled receptor. Clin. Cancer Res. 13, 5926-5934.
De Vries, L., Zheng, B., Fischer, T., Elenko, E., Farquhar, M.G., 2000. The regulator of G pro-
tein signaling family. Ann. Rev. Pharmacol. Toxicol. 40, 235-271.
De Wilde, R.F., Ottenhof, N.A., Jansen, M., Morsink, F.H.M., de Leng, W.W.J., Offerhaus,
G.J.A., et al., 2011. Analysis of LKB1 mutations and other molecular alterations in pan-
creatic acinar cell carcinoma. Mod. Pathol. 24, 1229-1236.
Di Agostino, S., Strano, S., Blandino, G., 2010. YAP1 (Yes-associated protein 1, 65kDa).
Atlas Genet. Cytogenet. Oncol. Haematol. < http://AtlasGeneticsOncology.org/Genes/
YAP1ID42855ch11q22.html >.
Dillon, R.L., Brown, S.T., Ling, C., Shioda, T., Muller, W.J., 2007. An EGR2/CITED1 tran-
scription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating
ErbB2 expression in a transgenic-mouse model of human breast cancer. Mol. Cell. Biol.
27, 8648-8657.
Ding, L., Xu, Y.J., Zhang, W., Deng, Y.J., Si, M.S., Du, Y., et al., 2010. MiR-375 frequently
downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res.
20, 784-793.
Ding, L., Zhang, X., Zhao, M., Qu, Z., Huang, S., Dong, M., et al., 2012. An essential role
of PDCD4 in progression and malignant proliferation of gastrointestinal stromal tumors.
Med. Oncol. 29, 1758-1764.
Ding, Y., Boguslawski, E.A., Berghuis, B.D., Young, J.J., Zhang, Z., Hardy, K., et al., 2008.
Mitogen-activated protein kinase kinase signaling promotes growth and vascularization
of fibrosarcoma. Mol. Cancer Ther. 7, 648-658.
Distler, J.H., Distaler, O., 2010. Tyrosine kinase inhibitors for the treatment of fibrotic dis-
eases such as systemic sclerosis: towards molecular targeted therapies. Ann. Rheum. Dis.
69 (Suppl), i48-i51.
Djos, A., Martinsson, T., Kigner, P., Caren, H., 2012. The RASSF genes family members
RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.
Mol. Cancer 11, 40.
Doench, J.G., Petersen, C.P., Sharp, P.A., 2003. siRNAs can function as miRNAs. Genes Dev.
17, 438-442.
Doherty, N.G., O'Sullivan, O.E., Healy, D.A., Murphy, M., O'Neill, A.J., Fitzpatrick, J.M.,
et al., 2006. TGF-β 1 -induced EMT can occur independently of its proapoptotic effects and
is aided by EGF receptor activation. Am. J. Physiol. Renal. Physiol. 290, F1202-F1212.
Dong, J.T., Lamb, P.W., Rinker-Schaeffer, C.W., Vukanovic, J., Ichikaa, T., Isscas, J.T., et al.,
1995. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome
11p11.2. Science 268, 884-886.
Dong, M., How, T., Kirkbride, K.C., Gordon, K.J., Lee, J.D., Hempel, N., et al., 2007a. The type
III TGF-beta receptor suppresses breast cancer progression. J. Clin. Invest. 117, 206-217.
Dong, P., Kaneuchi, M., Watari, H., Hamada, J., Sudo, S., Ju, J., et al., 2011a. MicroRNA-194
inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol. Cancer 10, 99.
Dong, J., Huang, S., Caikovski, M., Ji, S., McGrath, A., Custorio, M.G, et al. 2011b. ID4 regu-
lates mammary gland development by suppressing p38MAPK activity. Development 138,
5247-5256.